{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:44:25Z","timestamp":1788443065362,"version":"build-2803163510"},"reference-count":40,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007293","name":"Obesity Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007293","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018188","name":"Clinical and Translational Science Institute","doi-asserted-by":"publisher","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}],"id":[{"id":"10.13039\/100018188","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Florida Clinical and Translational Science"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>The mechanisms leading to increased cardiovascular disease in patients with nonalcoholic fatty liver disease (NAFLD) and advanced liver fibrosis remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study assessed HDL-bound proteins in patients with NAFLD with or without advanced fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study at a university hospital included 185 patients with or without type 2 diabetes (T2D). Patients underwent liver proton magnetic resonance spectroscopy to measure intrahepatic triglyceride accumulation and those with NAFLD underwent a percutaneous liver biopsy. Advanced lipid testing with lipoprotein subfraction measurements and targeted proteomics of HDL-bound proteins was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with and without advanced fibrosis had similar clinical characteristics, except for lower HDL-C (34 \u00b1 8 vs 38 \u00b1 9\u2005mg\/dL, P = 0.024) and higher prevalence of T2D in advanced fibrosis. Patients with advanced fibrosis had lower HDL particle number. A panel of 28 HDL-bound proteins were targeted and quantified by multiple reaction monitoring liquid chromatography\u2013tandem mass spectrometry. Five proteins were found to be decreased in patients with advanced fibrosis (ApoC-I [P &amp;lt; 0.001], ApoC-IV [P = 0.012], ApoM [P = 0.008], LCAT [P = 0.014], and SAA4 [P = 0.016]). No differences were observed in these proteins in patients with vs without NAFLD or steatohepatitis. The pCAD index, associated with coronary artery disease and cardiovascular mortality, was significantly higher in patients with advanced fibrosis (97 \u00b1 5 vs 86 \u00b1 25, P = 0.04).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with NAFLD with advanced fibrosis showed significant differences in HDL-bound protein levels; this translated into increased cardiovascular risk based on pCAD index. Different lipoprotein composition and function may explain the link between liver disease and increased cardiovascular mortality in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgac565","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T14:02:13Z","timestamp":1664460133000},"page":"42-51","source":"Crossref","is-referenced-by-count":21,"title":["Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-4396","authenticated-orcid":false,"given":"Fernando","family":"Bril","sequence":"first","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Alabama at Birmingham , Birmingham, AL 35233 , USA"},{"name":"Division of Endocrinology, Diabetes and Metabolism, Birmingham VA Medical Center , Birmingham, AL 35233 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan W","family":"Pearce","sequence":"additional","affiliation":[{"name":"Quest Diagnostics Cardiometabolic Center of Excellence, Cleveland HeartLab , Cleveland, OH 44103 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S","family":"Collier","sequence":"additional","affiliation":[{"name":"Quest Diagnostics Cardiometabolic Center of Excellence, Cleveland HeartLab , Cleveland, OH 44103 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4399-5733","authenticated-orcid":false,"given":"Michael J","family":"McPhaul","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes & Metabolism, Quest Diagnostics Nichols Institute , San Juan Capistrano, CA 92675 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"issue":"1","key":"2022121716480443900_dgac565-B1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"2022121716480443900_dgac565-B2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1573402116999201209203534","article-title":"Nonalcoholic Fatty Liver Disease (NAFLD) for primary care providers: beyond the liver","volume":"17","author":"Godinez-Leiva","year":"2021","journal-title":"Curr Hypertens Rev"},{"issue":"2","key":"2022121716480443900_dgac565-B3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jc.2015-3111","article-title":"Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD","volume":"101","author":"Bril","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2022121716480443900_dgac565-B4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.28985","article-title":"Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease","volume":"65","author":"Bril","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"2022121716480443900_dgac565-B5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"issue":"12","key":"2022121716480443900_dgac565-B6","doi-asserted-by":"crossref","first-page":"e115403","DOI":"10.1371\/journal.pone.0115403","article-title":"LDL-Migration Index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study","volume":"9","author":"Imajo","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"2022121716480443900_dgac565-B7","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","article-title":"Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile","volume":"13","author":"Siddiqui","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2022121716480443900_dgac565-B8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"2022121716480443900_dgac565-B9","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"2022121716480443900_dgac565-B10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/apt.15660","article-title":"Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease","volume":"51","author":"Henson","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2022121716480443900_dgac565-B11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"2022121716480443900_dgac565-B12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10620-020-06196-4","article-title":"Progression to cirrhosis leads to improvement in atherogenic milieu","volume":"66","author":"Patel","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2022121716480443900_dgac565-B13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jhep.2020.01.026","article-title":"HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure","volume":"73","author":"Trieb","year":"2020","journal-title":"J Hepatol"},{"issue":"1","key":"2022121716480443900_dgac565-B14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jim-2015-000019","article-title":"Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes","volume":"64","author":"Bril","year":"2016","journal-title":"J Investig Med"},{"issue":"2","key":"2022121716480443900_dgac565-B15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jhep.2014.08.040","article-title":"Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis","volume":"62","author":"Bril","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"2022121716480443900_dgac565-B16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc17-1349","article-title":"Clinical and histologic characterization of nonalcoholic steatohepatitis in African American patients","volume":"41","author":"Bril","year":"2018","journal-title":"Diabetes Care"},{"issue":"5","key":"2022121716480443900_dgac565-B17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"2022121716480443900_dgac565-B18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/acs.jproteome.7b00816","article-title":"Rapid affinity enrichment of human apolipoprotein A-I associated lipoproteins for proteome analysis","volume":"17","author":"Collier","year":"2018","journal-title":"J Proteome Res"},{"issue":"2","key":"2022121716480443900_dgac565-B19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1373\/clinchem.2018.291922","article-title":"Development and validation of apolipoprotein AI-associated lipoprotein proteome panel for the prediction of cholesterol efflux capacity and coronary artery disease","volume":"65","author":"Jin","year":"2019","journal-title":"Clin Chem"},{"issue":"17","key":"2022121716480443900_dgac565-B20","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jacc.2019.01.073","article-title":"Association of an HDL apolipoproteomic score with coronary atherosclerosis and cardiovascular death","volume":"73","author":"Natarajan","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2022121716480443900_dgac565-B21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jhep.2019.09.018","article-title":"Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis","volume":"72","author":"Bril","year":"2020","journal-title":"J Hepatol"},{"issue":"9","key":"2022121716480443900_dgac565-B22","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/liv.12840","article-title":"Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients","volume":"35","author":"Bril","year":"2015","journal-title":"Liver Int"},{"issue":"1","key":"2022121716480443900_dgac565-B23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"2022121716480443900_dgac565-B24","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","author":"European Association for the Study of the Liver (EASL)","year":"2016","journal-title":"Diabetologia"},{"issue":"6","key":"2022121716480443900_dgac565-B25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"2022121716480443900_dgac565-B26","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"issue":"11","key":"2022121716480443900_dgac565-B27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"2022121716480443900_dgac565-B28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","article-title":"Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis","volume":"157","author":"Cicognani","year":"1997","journal-title":"Arch Intern Med"},{"issue":"7","key":"2022121716480443900_dgac565-B29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbalip.2016.04.013","article-title":"Liver disease alters high-density lipoprotein composition, metabolism and function","volume":"1861","author":"Trieb","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2022121716480443900_dgac565-B30","doi-asserted-by":"crossref","first-page":"e8793","DOI":"10.15252\/msb.20188793","article-title":"Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease","volume":"15","author":"Niu","year":"2019","journal-title":"Mol Syst Biol"},{"key":"2022121716480443900_dgac565-B31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cca.2020.10.023","article-title":"The apoM-S1P axis in hepatic diseases","volume":"511","author":"Chen","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2022121716480443900_dgac565-B32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jhep.2021.06.043","article-title":"Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis","volume":"75","author":"Cl\u00e0ria","year":"2021","journal-title":"J Hepatol"},{"issue":"10","key":"2022121716480443900_dgac565-B33","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.7150\/ijms.8330","article-title":"Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's Liver","volume":"11","author":"Luo","year":"2014","journal-title":"Int J Med Sci"},{"issue":"47","key":"2022121716480443900_dgac565-B34","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.3748\/wjg.v12.i47.7604","article-title":"New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples","volume":"12","author":"G\u00f6bel","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"16","key":"2022121716480443900_dgac565-B35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM197010152831604","article-title":"Serum cholesterol esterification in liver disease","volume":"283","author":"Simon","year":"1970","journal-title":"N Engl J Med"},{"issue":"1","key":"2022121716480443900_dgac565-B36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12933-015-0221-4","article-title":"Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus","volume":"14","author":"Shen","year":"2015","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2022121716480443900_dgac565-B37","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/ATVBAHA.119.312556","article-title":"Albuminuria, the high-density lipoprotein proteome, and coronary artery calcification in type 1 diabetes Mellitus","volume":"39","author":"Shao","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2022121716480443900_dgac565-B38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jacl.2015.03.010","article-title":"Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease","volume":"9","author":"Sonmez","year":"2015","journal-title":"J Clin Lipidol"},{"key":"2022121716480443900_dgac565-B39","doi-asserted-by":"crossref","first-page":"271062","DOI":"10.1155\/2011\/271062","article-title":"The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis","volume":"2011","author":"Hansen","year":"2011","journal-title":"J Lipids"},{"issue":"5","key":"2022121716480443900_dgac565-B40","doi-asserted-by":"crossref","first-page":"e98368","DOI":"10.1371\/journal.pone.0098368","article-title":"A pro-atherogenic HDL profile in coronary heart disease patients: an iTRAQ labelling-based proteomic approach","volume":"9","author":"Yan","year":"2014","journal-title":"PLoS One"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac565\/46542751\/dgac565.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/1\/42\/48076729\/dgac565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/1\/42\/48076729\/dgac565.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:48:42Z","timestamp":1671277722000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/1\/42\/6731241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,9,29]]},"published-print":{"date-parts":[[2022,12,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac565","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,9,29]]}}}